At a glance

  • Vaccines are one of the world’s most cost-effective health tools, saving 3.5 to 5 million lives each year.
  • Countries around the globe have made impressive strides in combating vaccine-preventable diseases—including eradicating smallpox and dramatically reducing the number of people falling ill or dying from diseases such as polio, pneumonia, rotavirus, and measles.
  • In recent years, progress has stalled as routine immunization programs and basic health care services faced major disruptions, resulting in significant decreases in immunization coverage rates, which have not fully recovered. In 2023, 14.5 million children did not receive a single vaccine, compared with 13.9 million the previous year.
  • We support the delivery of lifesaving vaccines to places with some of the highest rates of unimmunized children.
  • As part of Gavi, the Vaccine Alliance, our team works with country governments, the World Health Organization (WHO), UNICEF, the World Bank, and a wide range of national, local, and global partners to provide new and underused vaccines to millions of people in lower-income countries.


Our strategy

The Immunization team supports new approaches to immunization challenges and funds solutions that accelerate the uptake and delivery of high-quality, affordable vaccines, in collaboration with Gavi, WHO, UNICEF, governments, civil society organizations, and the private sector.

Our work is organized around five priorities:

  • Gavi and partners. We support Gavi and global and regional immunization partners in reaching more children with vaccines, including through the rollout of Gavi’s 6.0 (2025–2030) strategy.
  • Vaccine access. We work to ensure that vaccines supported by Gavi are affordable, in adequate supply, and available where they are needed, by investing in market shaping, supply chain visibility, and cold chains.
  • Vaccine delivery programs. We work to make immunization efforts more effective by bridging on-the-ground realities and global priorities, through systems support as well as disease-specific programs.
  • High-impact countries. We focus in particular on improving immunization coverage in Nigeria, Ethiopia, India, and Pakistan.
  • Equity geographies. We work to improve vaccine coverage at the subnational level in fragile settings, including in the Democratic Republic of the Congo, Somalia, and the Lake Chad Basin.

We believe that robust, resilient immunization programs are the cornerstone of strong primary health care systems. Our work contributes to the Immunization Agenda 2030, a global vision to extend the full benefits of immunization to all by 2030, which also aligns with Gavi’s 6.0 strategy.

Sabitas' child receives a pneumococcal conjugate vaccine (PCV) from an Auxiliary Nurse Midwife (ANM) Worker. The PCV gives protection against 13 types of pneumococcal bacteria that all cause pneumococcal disease at an Anganwadi Centre (AWC) in Bhopal, Madhya Pradesh, India on September 26, 2018.
Sabitas’ child receives a pneumococcal conjugate vaccine from an Auxiliary Nurse Midwife Worker at an Anganwadi Centre in Bhopal, Madhya Pradesh, India. ©Gates Archive/Mansi Midha

Latest grants

Areas of focus

We work with local, national, and global partners to ensure that vaccines are affordable and vaccine delivery aligns with local demand, especially in areas with the lowest immunization coverage. As part of Gavi, our foundation works with WHO, UNICEF, the World Bank, and others to support vaccine introductions, scale up efforts, and strengthen health systems.

Gavi and partners

We support Gavi as the primary channel for working with lower-income countries to expand access to vaccines and build strong, sustainable immunization programs. We also work to strengthen a broader ecosystem of partners—at the global, regional, and country levels—to help Gavi fulfill its mission of ensuring equitable access to lifesaving vaccines.


Vaccine access

We help make high-quality and affordable vaccines available by ensuring that supply meets demand, procurement is effective and efficient, and supply chains deliver vaccines when and where they are needed. We focus on using data to inform strong decision-making and accountability and to identify gaps in the partner ecosystem that can be filled through our financial support and expertise.


Vaccine delivery programs

We work to advance global immunization priorities while supporting countries in strengthening immunization coverage. Our work spans two interconnected areas: systems support—such as for demand generation, service delivery transformation, modeling and measurement, and country decision-making—and disease-specific efforts, with a focus on measles, human papillomavirus, and hexavalent vaccines, as well as specific new vaccine introductions and switches.​The goal is to help align on-the-ground realities and global priorities, ensuring that each informs the other.


High-impact countries

In collaboration with governments and local, national, and global partners, we work to strengthen immunization systems and delivery pathways to reach underserved communities in some of the largest countries with remaining gaps in immunization coverage. We work at both the federal and subnational levels to address barriers to access, with a focus on bolstering coverage in underimmunized communities.


Equity geographies

We work to improve routine immunization coverage in areas where coverage gaps are most concentrated and conventional delivery models are less effective, including in fragile settings. We focus on rapid learning, impact measurement, and building strong partnerships, and we apply lessons to the broader immunization sector’s understanding of replicable and sustainable approaches to improving coverage.


Advocacy and communications

We work closely with country leaders, development partners, civil society organizations, WHO, UNICEF, the World Bank, and others on vaccine advocacy. This includes mobilizing funding for Gavi, supporting advocates and immunization champions in raising awareness of the importance of strengthening routine immunization, and ensuring that sufficient funding and strong policies are in place to support vaccine introductions and the scaling up of immunization efforts.


Why focus on immunization ?

In 1997, after reading a newspaper article about the millions of children dying of preventable diseases in lower-income countries each year, Bill Gates and Melinda French Gates were driven to act, laying the groundwork for the foundation’s immunization work.

Vaccines are among the safest and most effective medical products ever developed, and they protect people from deadly and debilitating diseases. Since WHO launched the Expanded Programme on Immunization in 1974, vaccines have saved the lives of an estimated 154 million people, most of them children—equivalent to six lives saved every minute. Vaccines have eradicated smallpox and turned diseases like measles, polio, meningitis A, and rotavirus from leading killers into preventable illnesses.

That progress hasn’t reached every child, however. Each year, millions of children receive no vaccines in their first year, more than half of them living in fragile and conflict-affected areas. These gaps leave children and communities exposed to diseases that are preventable. When vaccination rates slip, diseases that were previously under control can come back, and children in lower-income countries, who already have the highest burden of vaccine-preventable deaths, are hit hardest.

Closing these gaps can have ripple effects that extend far beyond the individual child. Vaccines protect children from diseases that can limit their development and keep them out of school. They also spare families from costly medical bills—potentially preventing millions of people in lower-income countries from falling into poverty due to health expenses if 2030 coverage targets are met. With less preventable illness to manage, governments can put resources toward other health priorities. Those gains can compound across entire economies: Every $1 spent on vaccines in lower-income countries yields an estimated $54 in economic benefits.

Dawai poses for a photo with his mom Poline during a door to door polio vaccine campaign in Adia, Cameroon on March 3, 2018.
Dawai poses for a photo with his mom Poline during a door to door polio vaccine campaign in Adia, Cameroon. ©Gates Archive/Dominique Catton

We believe that every child should be protected, no matter where they’re born. Reaching this goal will take innovation at every step, from the lab to the last mile. That means supporting development of vaccines that are more affordable and effective and finding better ways to store, transport, and deliver them. It also means working alongside countries and other partners so those vaccines reach every community. Our foundation’s largest grantee is Gavi, which has successfully accelerated vaccine introductions and improved immunization coverage in lower-income countries. From 2000 to 2025, Gavi and its partners immunized over 1.3 billion children, preventing more than 23 million deaths and generating more than US$308 billion in economic benefits.

The problem described in that 1997 newspaper article is smaller today, thanks in large part to vaccines, but the story isn’t over. With the tools we have today, we can ensure that it ends with every child protected.